Open AccessNationwide Implementation of Pathogen Inactivation for All Platelet Concentrates in Switzerland
Author(s) -
Markus Jutzi,
Behrouz Mansouri Taleghani,
Morven Rueesch,
Lorenz Amsler,
Andreas Buser
Publication year - 2018
Publication title -
transfusion medicine and hemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.971
H-Index - 39
eISSN - 1660-3818
pISSN - 1660-3796
DOI - 10.1159/000489900
Subject(s) - platelet , pathogen , medicine , blood preservation , intensive care medicine , immunology , biology , physiology
Bacterial contamination of platelet concentrates (PCs) has been identified as the most prevalent transfusion-associated infectious risk. To prevent PC-related septic transfusion reactions, the Intercept® pathogen inactivation procedure was introduced for all PCs in Switzerland in 2011.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom